The reconstituted solution should be clear and colourless
Available from: Hergovich N, et al
Clinical trial results for retatrutide have exceeded even the high expectations set by tirzepatide, with Phase 2 data published in the New England Journal of Medicine in 2023 demonstrating weight loss approaching 24-25% of baseline body weight over 48 weeks in some dose groups - weight reductions comparable to those achieved with bariatric surgery and substantially exceeding pharmacological obesity treatments available just a few years ago
GLP-1 agonists like Wegovy mimic this naturally occurring hormone, which improves blood sugar levels, slows down digestion, and helps you feel satiated
By inhibiting NNMT, 5Amino1MQ Peptide reshapes the metabolic phenotype of adipose tissue, promotes lipolysis, increases energy expenditure, and restores dynamic balance of fat metabolism - one of its core weightloss mechanisms
HumeCare+ is a reasonable option to look into if you want GLP-1 treatment paired with active clinical oversight and you're specifically interested in protecting lean muscle mass during weight loss, rather than just watching a number on a scale drop
